Results 161 to 170 of about 6,787,265 (281)
Launch Opportunities and Preliminary Orbit Design for Next Mars Exploration Program
OGAWA, Naoko +9 more
openaire +2 more sources
Animal-assisted resilience in space exploration: a human factors approach to astronaut behavioral health. [PDF]
Kim DW.
europepmc +1 more source
ABSTRACT Background The clinical relevance of MGMT promoter methylation in IDH‐mutant gliomas remains controversial in the era of molecular classification. We aimed to systematically evaluate its clinical relevance by integrating quantitative assessment, cutoff exploration, and adjustment for clinical confounding.
Haihui Jiang +7 more
wiley +1 more source
Plasma acceleration and boundary compression in the magnetosheath of Mars under low-Alfvén-Mach-number solar wind. [PDF]
Qiao F +20 more
europepmc +1 more source
ABSTRACT Objective To identify inflammatory analytes in cerebrospinal fluid (CSF) and plasma associated with cognitive decline in cognitively normal (CN) older adults at risk for Alzheimer's disease (AD). Methods In a longitudinal study of 118 CN older adults (65–80 years, 54% APOE ε4, 26% preclinical AD), 1331 CSF and 1501 plasma analytes were ...
Jagan A. Pillai +13 more
wiley +1 more source
Launch Opportunities and Preliminary Orbit Design for Next Mars Exploration Program
資料番号 ...
openaire +1 more source
Mars planetary insights and design framework for future in-situ aerial robotic missions. [PDF]
Youhanna V, Felicetti L, Ignatyev D.
europepmc +1 more source
Generalized Dystonia With Cervical Predominance in a Patient With a De Novo TCF20 Variant
ABSTRACT TCF20 has been implicated in developmental delay and intellectual disability, with dystonia reported less frequently. We describe a woman in her early twenties with childhood‐onset learning difficulties, progressive dysarthria, tremor, and generalized dystonia with marked cervical predominance, associated with a de novo TCF20 frameshift ...
Melisa Kilic +7 more
wiley +1 more source
ABSTRACT Objective Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP‐A) is an inflammatory central nervous system disorder with variable outcomes. Relapse occurs in a subset of patients, but early predictors remain unclear. We aimed to identify admission‐available features associated with 1‐year recurrence and develop an interpretable ...
Qingting Hong +10 more
wiley +1 more source

